<DOC>
	<DOCNO>NCT02127021</DOCNO>
	<brief_summary>Up , study concern nutritional assessment pancreatic resection rare . The low-dose pancreatic enzyme treatment pancreatectomy show significant benefit term nutritional status . This study multicenter randomize phase IV study use high-dose Norzyme® ( 40,000 IU ) evaluate quality life nutritional status pancreaticoduodenectomy .</brief_summary>
	<brief_title>The Effects High Dose Pancreatic Enzyme Replacement Therapy After Pancreatoduodenectomy</brief_title>
	<detailed_description>There enough study evaluate nutritional parameter patient pancreatic resection . After pancreatic surgery , several way improve patient condition term quality life include nutrition . In investigator previous study , pancreatic enzyme supplement administration Norzyme® 25000 IU contain lipase 25000 IU , amylase 22500 IU , protease 1250 IU various type pancreatectomy improve quality life nutritional status fail prove effectiveness . After administration low-dose Norzyme® ( 25000 IU ) , patient show weight gain , statistically significant conclusion obtain mainly various type pancreatectomy low supplementary dosage pancreatic enzyme . Therefore , investigator design study find effect high-dose Norzyme® ( 40000 IU ) weight gain , quality life , stool habit change , nutritional status patient pancreaticoduodenectomy . The investigator evaluate effectiveness adequacy high-dose pancreatic supplementary treatment randomize , placebo-using , single-blinded , multicenter study .</detailed_description>
	<criteria>Age 18 75 year ECOG performance status : 0,1,2 Patients underwent pancreaticoduodenectomy pylorus preserve pancreaticoduodenectomy stool elastase ≤200 , preoperatively postoperatively Patients consent study Patients comorbidities liver cirrhosis , chronic renal failure , heart failure , inflammatory bowel disease affect assessment quality life nutritional status Patients underwent major abdominal organ surgery gastrectomy colon resection affect assessment quality life nutritional status Patients locoregional recurrence distant metastasis Patients able progress diet medication within 10 day surgery Patients pork allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pancreaticoduodenectomy</keyword>
	<keyword>Nutritional Status</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Biochemical Marker</keyword>
</DOC>